Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized 2% lidocaine for sedation support during awake intubation
IRCT20180806040724N2Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of lidocaine, sponsored by Tabriz University of Medical Sciences. Started Jan 2019; status: completed.
02
Drugs
lidocaine
Beyond the preview
Go deeper on IRCT20180806040724N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180806040724N2.